Relay Therapeutics (RLAY) Interest & Investment Income (2019 - 2026)
Relay Therapeutics' (RLAY) quarterly Interest & Investment Income came in at -$172000.0 in Q1 2026, down 102.2% year-on-year from $7.8 million in Q1 2025, and down 100.67% on a QoQ basis from $25.6 million in Q4 2025.
Relay Therapeutics (RLAY) Interest & Investment Income (2019 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has 8 years of Interest & Investment Income data on file, last reported at -$172000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 102.2% year-over-year to -$172000.0 in Q1 2026; TTM through Mar 2026 was $38.9 million, a 31.38% decrease from a year earlier, with the FY2025 full-year figure at $27.0 million, down 22.19% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$172000.0, down from $25.6 million in the prior quarter.
- Over the last five years, Interest & Investment Income for RLAY reached as high as $32.0 million in Q4 2024 and fell as low as -$8.1 million in Q1 2022.
- Historically, Interest & Investment Income has averaged $6.7 million across 5 years, with a median of $6.4 million in 2025.
- Across the five-year window, Interest & Investment Income tumbled 3697.35% in 2022 and jumped 3163.44% in 2024, its largest moves.
- Year by year, Interest & Investment Income stood at $5.4 million in 2022, then sank by 40.62% to $3.2 million in 2023, then surged by 904.42% to $32.0 million in 2024, then declined by 20.26% to $25.6 million in 2025, then slumped by 100.67% to -$172000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were -$172000.0 in Q1 2026, $25.6 million in Q4 2025, and $6.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Relay Therapeutics | 3.35 Bn | 3.35 Bn | - | -172,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -172,000.00 |
| Dec 31, 2025 | 25.55 Mn |
| Sep 30, 2025 | 6.41 Mn |
| Jun 30, 2025 | 7.11 Mn |
| Mar 31, 2025 | 7.81 Mn |
| Dec 31, 2024 | 32.04 Mn |
| Sep 30, 2024 | 8.27 Mn |
| Jun 30, 2024 | 8.55 Mn |
| Mar 31, 2024 | 8.95 Mn |
| Dec 31, 2023 | 3.19 Mn |
| Sep 30, 2023 | 2.70 Mn |
| Jun 30, 2023 | -279,000.00 |
| Mar 31, 2023 | 6.94 Mn |
| Dec 31, 2022 | 5.37 Mn |
| Sep 30, 2022 | 1.71 Mn |
| Jun 30, 2022 | -2.69 Mn |
| Mar 31, 2022 | -8.13 Mn |
| Dec 31, 2021 | -1.72 Mn |
| Sep 30, 2021 | 74,000.00 |
| Jun 30, 2021 | -76,000.00 |